US Lifts Nvidia China Restrictions: NVDA Poised to Recover 25% Revenue Loss

In a stunning reversal of US-China technology restrictions, the Biden administration has cleared the way for unrestricted Nvidia chip sales to Chinese firms, effectively unlocking what had been a critical revenue stream worth approximately 25% of the chipmaker's total income. The move signals a marked shift in technology policy dynamics amid the Trump-Xi summit in Beijing, where both nations have signaled a desire to stabilize relations and reduce trade tensions.

The specific catalyst for the policy shift remains tied to broader US-China trade normalization efforts. According to multiple sources flagging this development, the restoration of Nvidia access represents the single largest revenue recovery opportunity for the semiconductor giant, as China had been forced to pivot to domestic alternatives and second-tier suppliers since the initial export controls were imposed. The timing is notable given that Nvidia's recent data center and AI infrastructure dominance has made it an increasingly critical dependency for global AI model training and inference workloads; China's inability to access the latest H-series GPUs had created significant competitive friction.

For equity traders, the implications are substantial. NVDA has already benefited from broad AI infrastructure tailwinds, but the China reversal removes a systematic discount that had been baked into valuation multiples. Competing semiconductor names like AMD and Broadcom (AVGO) that had sought to fill the China gap with export-compliant alternatives now face margin pressure as Nvidia potentially recaptures share. Meanwhile, the broader chipmaker complex (SMH, XSD) rallies on the view that geopolitical de-escalation could unlock additional supply-chain efficiencies and reduce the need for redundant domestic capacity buildout.

Skeptics note that a full reversal remains uncertain; congressional opposition to chip liberalization persists, and implementation details around monitoring and export controls could still constrain actual sales volumes. Additionally, Chinese firms have already invested heavily in alternative suppliers and domestic R&D, which may slow the pace of revenue repatriation. Nonetheless, market pricing has already begun to reflect a material upside scenario.